DE3430320A1 - Verfahren zur herstellung von immunglobulin-praeparaten mit verminderter komplementaktivitaet - Google Patents

Verfahren zur herstellung von immunglobulin-praeparaten mit verminderter komplementaktivitaet

Info

Publication number
DE3430320A1
DE3430320A1 DE19843430320 DE3430320A DE3430320A1 DE 3430320 A1 DE3430320 A1 DE 3430320A1 DE 19843430320 DE19843430320 DE 19843430320 DE 3430320 A DE3430320 A DE 3430320A DE 3430320 A1 DE3430320 A1 DE 3430320A1
Authority
DE
Germany
Prior art keywords
immunoglobulin
solution
concentration
polyethylene glycol
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19843430320
Other languages
German (de)
English (en)
Inventor
Yasuo Yokohama Kanagawa Shibata
Takeshi Chiba Suehiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIHON SEIYAKU CO
Original Assignee
NIHON SEIYAKU CO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NIHON SEIYAKU CO filed Critical NIHON SEIYAKU CO
Publication of DE3430320A1 publication Critical patent/DE3430320A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19843430320 1983-08-18 1984-08-17 Verfahren zur herstellung von immunglobulin-praeparaten mit verminderter komplementaktivitaet Withdrawn DE3430320A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14968883A JPS6042336A (ja) 1983-08-18 1983-08-18 免疫グロブリンの製造方法

Publications (1)

Publication Number Publication Date
DE3430320A1 true DE3430320A1 (de) 1985-03-28

Family

ID=15480636

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19843430320 Withdrawn DE3430320A1 (de) 1983-08-18 1984-08-17 Verfahren zur herstellung von immunglobulin-praeparaten mit verminderter komplementaktivitaet

Country Status (2)

Country Link
JP (1) JPS6042336A (enExample)
DE (1) DE3430320A1 (enExample)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
US5525519A (en) * 1992-01-07 1996-06-11 Middlesex Sciences, Inc. Method for isolating biomolecules from a biological sample with linear polymers
US7138120B2 (en) 1998-06-09 2006-11-21 Statens Serum Institut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
US8715652B2 (en) 2003-11-18 2014-05-06 Csl Behring Ag Immunoglobulin preparations having increased stability
US9241897B2 (en) 2010-02-04 2016-01-26 Csl Behring Ag Immunoglobulin preparation
US9422364B2 (en) 2010-02-26 2016-08-23 Csl Behring Ag Immunoglobulin preparation and storage system for an immunoglobulin preparation
US9631007B2 (en) 2005-05-25 2017-04-25 Hoffmann-La-Roche Inc. Method for the purification of antibodies
US12144861B2 (en) 2014-12-03 2024-11-19 Csl Behring Ag Pharmaceutical product with increased stability comprising immunoglobulins

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
US6441144B1 (en) * 1999-05-20 2002-08-27 Alpha Therapeutic Corporation Method for repairing dual virally inactivated immune globulin for intravenous administration
JP2005320248A (ja) * 2002-04-22 2005-11-17 Mitsubishi Pharma Corp 免疫グロブリン製剤の製造方法

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
US4880913A (en) * 1986-12-02 1989-11-14 Schwab & Co. Ges.M.B.H. Process for the preparation of an immunoglobulin which can be administered intravenously and is stable in liquid form
US5525519A (en) * 1992-01-07 1996-06-11 Middlesex Sciences, Inc. Method for isolating biomolecules from a biological sample with linear polymers
US5599719A (en) * 1992-01-07 1997-02-04 Middlesex Sciences, Inc. Method for isolating biomolecules from a biological sample with linear polymers
US7138120B2 (en) 1998-06-09 2006-11-21 Statens Serum Institut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
US8715652B2 (en) 2003-11-18 2014-05-06 Csl Behring Ag Immunoglobulin preparations having increased stability
US8906368B2 (en) 2003-11-18 2014-12-09 Zlb Behring Ag Immunoglobulin preparations having increased stability
NO345362B1 (no) * 2005-05-25 2020-12-28 Hoffmann La Roche Fremgangsmåte for rensing av antistoffer
US9631007B2 (en) 2005-05-25 2017-04-25 Hoffmann-La-Roche Inc. Method for the purification of antibodies
US11034754B2 (en) 2005-05-25 2021-06-15 Hoffmann-La Roche Inc. Method for the purification of antibodies
US10137197B2 (en) 2010-02-04 2018-11-27 Csl Behring Ag Process for preparing an immunoglobulin preparation
US9241897B2 (en) 2010-02-04 2016-01-26 Csl Behring Ag Immunoglobulin preparation
US12194101B2 (en) 2010-02-04 2025-01-14 Csl Behring Ag Process for preparing an immunoglobulin preparation
US9422364B2 (en) 2010-02-26 2016-08-23 Csl Behring Ag Immunoglobulin preparation and storage system for an immunoglobulin preparation
US10434176B2 (en) 2010-02-26 2019-10-08 Csl Behring Ag Immunoglobulin preparation and storage system for an immunoglobulin preparation
US11419936B2 (en) 2010-02-26 2022-08-23 Csl Behring Ag Immunoglobulin preparation and storage system for an immunoglobulin preparation
US12558422B2 (en) 2010-02-26 2026-02-24 Csl Behring Ag Immunoglobulin preparation and storage system for an immunoglobulin preparation
US12144861B2 (en) 2014-12-03 2024-11-19 Csl Behring Ag Pharmaceutical product with increased stability comprising immunoglobulins

Also Published As

Publication number Publication date
JPS6042336A (ja) 1985-03-06
JPH0582367B2 (enExample) 1993-11-18

Similar Documents

Publication Publication Date Title
EP0447585B1 (de) Verfahren zur Herstellung eines intravenös verträglichen Immunglobulin-G-Präparates
DE68922358T2 (de) Chromatographische Trennung von Plasmaproteinen, insbesondere von Faktor VIII, von Willebrand Faktor, von Fibronectin und von Fibrinogen.
DE2801123C2 (de) Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
EP0013901B1 (de) Verfahren zur Herstellung einer für die intravenöse Applikation geeigneten Immunglobulinlösung, die IgM in ankonzentrierter Form enthält
DE2936047C2 (enExample)
DE3825429A1 (de) Intravenoes verabreichbares polyklonales immunglobulin-praeparat mit hohem igm-gehalt und verfahren zu seiner herstellung
DE3786832T2 (de) Verfahren zur Herstellung von Immunoglobulinzubereitungen für intravenöse Injektion.
DE3641115A1 (de) Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
EP0122909A1 (de) Immunglobulin-G-hältige Fraktion
DE69326227T2 (de) Verfahren zur Isolation von hoch angereicherten Faktoren IX, X und II vom Prothrombin komplex oder menschlichem Plasma
DE2459291A1 (de) Verfahren zur gleichzeitigen herstellung von drei therapeutisch verwendbaren produkten aus einem ausgangsmaterial
DE3149360C2 (enExample)
DE3430320A1 (de) Verfahren zur herstellung von immunglobulin-praeparaten mit verminderter komplementaktivitaet
EP0085747B2 (de) Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
EP0111777B1 (de) Gerinnungsaktive Plasmaproteinlösung, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Störungen des Hämostasesystems
DE3686390T2 (de) Verfahren zur herstellung vom antihaemophilfaktor (ahf) durch kaeltefaellung und zur verbesserung der loeslichkeit des hergestellten ahf-produktes.
DE2742150C2 (enExample)
EP0123029B1 (de) Verfahren zur Herstellung einer nebenwirkungsfreien IgG-Immunglobulinlösung für die intravenöse Applikation
DE2658334C3 (de) Verfahren zum Herstellen von Immunglobulinpräparationen mit verminderter Komplementaktivität und ein diese enthaltendes Arzneimittel
EP0120835B1 (de) Verfahren zur Inaktivierung von Unverträglichkeitsreaktionen verursachenden Substanzen
CH630643A5 (en) Process for concentrating a placenta-specific glycoprotein.
CH628813A5 (en) Process for obtaining immunoglobulin
DE3001187C2 (enExample)
DE1940130C2 (de) Verfahren zur Reinigung von Insulin, nach diesem Verfahren gereinigtes Insulin und dessen Verwendung
EP0144714A2 (de) Verfahren zur Herstellung einer Serumproteinlösung

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: VOSSIUS, V., DIPL.-CHEM. DR.RER.NAT. TAUCHNER, P.,

8141 Disposal/no request for examination